gyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027

被引：52

作者：

Drudy, Denise ^{[1
]}

Kyne, Lorraine

O'Mahony, Rebecca

Fanning, Seamus

机构：

[1] Univ Coll Dublin, Ctr Food Safety, Sch Agr Food Sci & Vet Med, Dublin 4, Ireland

[2] Mater Misericordiae Univ Hosp, Dublin, Ireland

来源：

EMERGING INFECTIOUS DISEASES | 2007年 / 13卷 / 03期

关键词：

D O I：

10.3201/eid1303.060771

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：504 / 505

页数：2

共 10 条

[1] Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA [J].

Ackermann, G ;

Tang, YJ ;

Kueper, R ;

Heisig, P ;

Rodloff, AC ;

Silva, J ;

Cohen, SH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (08) :2348-2353

[2] gyrA and gyrB mutations are implicated in cross-resistance to ciprofloxacin and moxifloxacin in Clostridium difficile [J].

Dridi, L ;

Tankovic, J ;

Burghoffer, B ;

Barbut, F ;

Petit, JC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) :3418-3421

[3] High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile [J].

Drudy, Denise ;

Quinn, Teresa ;

O'Mahony, Rebecca ;

Kyne, Lorraine ;

O'Gaora, Peadar ;

Fanning, Seamus .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (06) :1264-1267

[4] Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea:: This is an antimicrobial resistance problem [J].

Gerding, DN .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (05) :646-648

[5] Mechanisms of fluoroquinolone resistance [J].

Hooper, DC .

DRUG RESISTANCE UPDATES, 1999, 2 (01) :38-55

[6] Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. [J].

Johnson, S ;

Samore, MH ;

Farrow, KA ;

Killgore, GE ;

Tenover, FC ;

Lyras, D ;

Rood, JI ;

DeGirolami, P ;

Baltch, AL ;

Rafferty, ME ;

Pear, SM ;

Gerding, DN .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (22) :1645-1651

[7] Emergence of Clostridium difficile-associated disease in North America and Europe [J].

Kuijper, E. J. ;

Coignard, B. ;

Tull, P. .

CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 :2-18

[8] Clostridium difficile [J].

Kyne, L ;

Farrell, RJ ;

Kelly, CP .

GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2001, 30 (03) :753-+

[9] Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe [J].

Warny, M ;

Pepin, J ;

Fang, A ;

Killgore, G ;

Thompson, A ;

Brazier, J ;

Frost, E ;

McDonald, LC .

LANCET, 2005, 366 (9491) :1079-1084

[10] In vitro activity of new generation fluoroquinolones against genotypically distinct and indistinguishable Clostridium difficile isolates [J].

Wilcox, MH ;

Fawley, W ;

Freeman, J ;

Brayson, J .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (04) :551-555

← 1 →